S&P 500

5.304,72

0,70%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Relmada Therapeutics Inc (RLMD)
Relmada Therapeutics Inc (RLMD) Notícias

RLMD

Relmada Therapeutics (RLMD)

Relmada Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:RLMD

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
08/05/2024	17:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RLMD	Relmada Therapeutics Inc
19/03/2024	08:27	IH Market News	US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat	NASDAQ:RLMD	Relmada Therapeutics Inc
20/02/2024	19:55	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RLMD	Relmada Therapeutics Inc
14/02/2024	10:53	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RLMD	Relmada Therapeutics Inc
31/01/2024	20:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RLMD	Relmada Therapeutics Inc
11/01/2024	18:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RLMD	Relmada Therapeutics Inc
21/06/2023	18:01	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:RLMD	Relmada Therapeutics Inc
30/05/2023	18:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RLMD	Relmada Therapeutics Inc
25/05/2023	17:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RLMD	Relmada Therapeutics Inc
12/05/2023	06:45	PR Newswire (US)	RLMD FRAUD ALERT: Jakubowitz Law is Investigating Relmada Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws	NASDAQ:RLMD	Relmada Therapeutics Inc
10/05/2023	06:45	PR Newswire (US)	INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Relmada Therapeutics, Inc. of an Investigation and Potential Class Action Lawsuit - (NYSE: RLMD)	NASDAQ:RLMD	Relmada Therapeutics Inc
31/03/2023	10:01	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:RLMD	Relmada Therapeutics Inc
14/02/2023	19:07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RLMD	Relmada Therapeutics Inc
09/02/2023	13:47	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RLMD	Relmada Therapeutics Inc
02/02/2023	19:02	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:RLMD	Relmada Therapeutics Inc
08/12/2022	00:15	TipRanks	Mizuho Securities Sticks to Their Buy Rating for Relmada Therapeutics (RLMD)	NASDAQ:RLMD	Relmada Therapeutics Inc
11/11/2022	08:55	TipRanks	Relmada Therapeutics (RLMD) Gets a Buy from Mizuho Securities	NASDAQ:RLMD	Relmada Therapeutics Inc
10/11/2022	18:09	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RLMD	Relmada Therapeutics Inc
17/10/2022	01:51	TipRanks	Analysts’ Top Healthcare Picks: InMode (INMD), Avidity Biosciences (RNA)	NASDAQ:RLMD	Relmada Therapeutics Inc
13/10/2022	13:36	TipRanks	Relmada Nosedives after Depression Therapy Fails in Phase 3	NASDAQ:RLMD	Relmada Therapeutics Inc
13/10/2022	08:45	TipRanks	Mizuho Securities Keeps Their Buy Rating on Relmada Therapeutics (RLMD)	NASDAQ:RLMD	Relmada Therapeutics Inc
07/10/2022	14:55	TipRanks	Relmada Therapeutics put volume heavy and directionally bearish	NASDAQ:RLMD	Relmada Therapeutics Inc
16/08/2022	05:45	TipRanks	SVB Securities Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD)	NASDAQ:RLMD	Relmada Therapeutics Inc
09/08/2022	10:21	Dow Jones News	Relmada Gets FDA Fast-Track Designation for REL-1017 as MDD Monotherapy	NASDAQ:RLMD	Relmada Therapeutics Inc
08/05/2022	21:45	TipRanks	Mizuho Securities Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD)	NASDAQ:RLMD	Relmada Therapeutics Inc
08/05/2022	12:11	TipRanks	Relmada Therapeutics (RLMD) Gets a Buy Rating from SVB Securities	NASDAQ:RLMD	Relmada Therapeutics Inc
07/04/2022	18:14	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	NASDAQ:RLMD	Relmada Therapeutics Inc
28/03/2022	21:36	TipRanks	Relmada Therapeutics (RLMD) Gets a Buy Rating from Mizuho Securities	NASDAQ:RLMD	Relmada Therapeutics Inc
25/03/2022	08:54	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:RLMD	Relmada Therapeutics Inc
29/12/2021	11:36	TipRanks	Analysts’ Top Healthcare Picks: LHC Group (LHCG), BridgeBio Pharma (BBIO)	NASDAQ:RLMD	Relmada Therapeutics Inc